Ambroxol, solution for injections/infusions 7.5 mg/ml, 2 ml each;Amiodarone, solution for injection, 50 mg/ml, 3 ml each;Drotaverin solution for injections 20 mg/ml, 2 ml in an ampoule;Quetiapine, film-coated tablets, 25 mg each;Lidocaine, solution for injection, 20 mg/ml, 2 ml each;Ethyl alcohol 96% 100 ml.;Chlorhexidine, solution for external use 0.05% per 100 ml;Pregabalin, capsules, 150 mg each;Iron preparation, solution for injections and infusions, 50 mg/ml, 2 ml each
By: Sophia Gula๐ UkraineOpen
Key Information
| Reference | GB-UA-2026-11-16-009573-a |
|---|
| Deadline | Nov 19, 2026 12:00 AM |
|---|
| Estimated Value | UAH 1,608,121.00 |
|---|
| Category | Advertising & Media |
|---|
| Competition Type | ICB |
|---|
| Funding Source | Self-Funded |
|---|
| Country | Ukraine |
|---|
| Address | 46001, Ukraine, Ternopil region, Ternopil city, str.Olena Kulchytska, 3 |
|---|
| Published | Nov 16, 2026 |
|---|
Description
Ambroxol, solution for injections/infusions 7.5 mg/ml, 2 ml each;Amiodarone, solution for injection, 50 mg/ml, 3 ml each;Drotaverin solution for injections 20 mg/ml, 2 ml in an ampoule;Quetiapine, fil...
Full details are available after unlocking this tender.